BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
30982942
Number of visits today
9187
Number of downloads
13512840
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Afkhami S, Villela AD, D'Agostino MR, Jeyanathan M, Gillgrass A, Xing Z. Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis. Front Immunol 2020;11:557809. [PMID: 33013927 DOI: 10.3389/fimmu.2020.557809] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chopra KK, Matta S, Arora VK. Impact of second wave of Covid-19 on tuberculosis control. Indian J Tuberc 2021;68:311-2. [PMID: 34099194 DOI: 10.1016/j.ijtb.2021.05.001] [Reference Citation Analysis]
2 Visca D, Ong CWM, Tiberi S, Centis R, D'Ambrosio L, Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M, Sotgiu G, Migliori GB, Goletti D. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology 2021;27:151-65. [PMID: 33547029 DOI: 10.1016/j.pulmoe.2020.12.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
3 Bouzeyen R, Javid B. Therapeutic Vaccines for Tuberculosis: An Overview. Front Immunol 2022;13:878471. [DOI: 10.3389/fimmu.2022.878471] [Reference Citation Analysis]
4 Bresser PL, Vorster M, Sathekge MM. An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging. Ann Nucl Med 2021;35:148-58. [PMID: 33400147 DOI: 10.1007/s12149-020-01563-7] [Reference Citation Analysis]
5 Guerrero GG, Rangel-moreno J, Islas-trujillo SO, Rojas-espinosa O. Intramuscular Boosting with hIFN-Alpha 2b Enhances BCGphipps-Induced Protection in a Murine Model of Leprosy. Microbiology Research 2021;12:711-26. [DOI: 10.3390/microbiolres12030051] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345